Stem Cells and Gastric Cancer
Stem Cells and Gastric Cancer
批准号:
8206700
负责人:
JEANMARIE HOUGHTON
金额:
$21.25万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-15 至 2013-12-31
关键词:
AddressApoptosisBone MarrowBone Marrow Stem CellBone Marrow TransplantationBypassCXCL12 geneCXCR4 geneCancer BiologyCancer EtiologyCancer ModelCarcinogensCarcinomaCell Culture TechniquesCell Differentiation processCell fusionCellsCharacteristicsChronicDataDisease ProgressionDysplasiaEngraftmentEpithelialEpithelial CellsEvaluationEventFutureGastric AdenocarcinomaGastric mucosaGene MutationGoalsGrantGrowthHelicobacterHelicobacter InfectionsHome environmentHomingIn VitroInfectionInflammationInjuryLaboratoriesLightLinkLuciferasesMalignant - descriptorMalignant NeoplasmsMarrowMesenchymal Stem CellsMetaplasiaModelingMusNeoplasm MetastasisPeripheralPlayPopulationPropertyReporterRoleStem cellsStomachStromal Cell-Derived Factor 1Supporting CellSurfaceSystemTechnologyTestingTimeTissuesTransplantationWorkbasecancer cellcancer initiationcancer preventioncancer stem cellcancer therapycell injurycell typecellular imagingin vivomalignant stomach neoplasmmouse modelnovelnovel strategiespreventpromoterreceptor expressionrecombinaseresearch studystability testingstem cell populationtumor
中文摘要
许多(如果不是大多数)恶性肿瘤与组织损伤和/或慢性炎症相关,然而,
炎症诱发癌症的机制直到最近仍不清楚。许多
癌细胞的特性,例如无限的生长潜力/避免凋亡和侵袭的能力/
转移潜能是骨髓衍生干细胞(BMDC)固有的特性。我
实验室已经表明,随着螺杆菌感染(一种已知的胃致癌物)BMDC回家,
移植并沿着化生-异型增生-癌序列分化,从而形成
胃癌的细胞基础使用体内和体外相结合的方法,我们的实验室已经确定了
胃干细胞作为骨髓来源的细胞。根据我们的研究结果,我们提出了一个新的模型,
这项新的RO 1提案将严格测试这种新的癌症形成模式,
良好描述的胃癌小鼠模型。在第一个具体目标中,我们将描述细胞内的
贴壁间充质干细胞(MSC)群体负责归巢和植入,
体外和体内实验的组合。在第二个具体目标中,我们将描述一个角色,
CXCR-4/SDF 1在动员MSC中的相互作用,并检测受体表达的稳定性。第三
具体目标我们将使用基于cre-lox的方法来确定聚变在这些事件中可能扮演的角色。
这些研究将采用原代MSC培养物的体外研究和体内骨研究相结合的方法。
慢病毒修饰的MSC群体的骨髓移植模型,并将为我们的研究奠定基础。
我们实验室的长期目标是确定BMDC在炎症诱导的上皮细胞中的作用,
癌症,并确定新的方法来预防和治疗癌症。
我们已经确定了骨髓干细胞在癌症形成中的作用。这项补助金将机械地
解决这些细胞如何导致癌症,并可能揭示治疗上皮癌的新方法。
英文摘要
Many, if not most malignancies are associated with tissue injury and/or chronic inflammation, however the
mechanisms responsible for inflammation induced cancer has until recently remained undefined. Many of
the properties of cancer cells such as unlimited growth potential/ability to avoid apoptosis and invasion /
metastasis potential are properties that are inherent to bone marrow derived stem cells (BMDC). My
laboratory has shown that with Helicobacter infection (a known gastric carcinogen) BMDC home to the
stomach, engraft and differentiate along a metaplasia-dysplasia-carcinoma sequence thus forming the
cellular basis of gastric cancer. Using a combined in vivo and in vitro approach, our laboratory has identified
the gastric stem cell as a bone marrow derived cell. Based on our findings, we propose a new model of
epithelial cancer.This new RO1 proposal will stringently test this new paradigm of cancer formation using our
well described gastric cancer mouse model. In the first specific aim, we will characterize the cell withinthe'
adherent mesenchymal stem cell (MSC) population responsible for homing and engraftment using a
combination of in vitro and in vivo experiments. In the second specific aim, we will characterize a role for
CXCR-4/SDF1 interaction in mobilization of MSC, and test the stability of receptor expression. In the third
specific aim we will use a cre-lox based approach to determine what role fusion may play in these events.
These studies will employ a combination of in vitro studies on primary MSC cultures as well as in vivo bone
marrow transplantation models of lentiviral modified MSC populations and will lay the ground work for our
long term objectives of our laboratory, which is to define the role of BMDC in inflammation induced epithelial
cancers and to identify novel approaches to cancer prevention and treatment.
We have identified a role for bone marrow stem cells in cancer formation. This grant will mechanistically
address how these cells cause cancer, and may shed light on new approaches to treat epithelial cancers.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Mesenchymal stem cells utilize CXCR4-SDF-1 signaling for acute, but not chronic, trafficking to gastric mucosal inflammation.
间充质干细胞利用CXCR4-SDF-1信号传导急性,但没有慢性运输到胃粘膜炎症。
DOI:
10.1007/s10620-013-2782-y
发表时间:
2013-09
期刊:
DIGESTIVE DISEASES AND SCIENCES
影响因子:
3.1
作者:
[Stoicov, Calin, Li, Hanchen, Liu, Jian Hua, Houghton, JeanMarie]
通讯作者:
Houghton, JeanMarie
Alcohol Effect on Human Breast Cancer Microenvironment
-
批准号:9133822
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2015
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Alcohol Effect on Human Breast Cancer Microenvironment
-
批准号:8816009
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2014
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Alcohol Effect on Human Breast Cancer Microenvironment
-
批准号:8664991
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2014
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Stem Cells and Gastric Cancer
-
批准号:7545502
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Inhibition of Fas-apoptosis in Gastric Cancer
-
批准号:7756584
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Inhibition of Fas-apoptosis in Gastric Cancer
-
批准号:7030018
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Inhibition of Fas-apoptosis in Gastric Cancer
-
批准号:7368070
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Inhibition of Fas-apoptosis in Gastric Cancer
-
批准号:7192533
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Stem Cells and Gastric Cancer
-
批准号:7185108
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Inhibition of Fas-apoptosis in Gastric Cancer
-
批准号:7559550
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Stem Cells and Gastric Cancer
-
批准号:7342880
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Stem Cells and Gastric Cancer
-
批准号:7019533
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Stem Cells and Gastric Cancer
-
批准号:8009435
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Stem Cells and Gastric Cancer
-
批准号:7748960
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2006
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Role of Fas/NF kB in H.pylori induced gastric carcinoma
-
批准号:6653165
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2001
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Role of Fas/NF kB in H.pylori induced gastric carcinoma
-
批准号:6495520
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2001
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
Role of Fas/NF kB in H.pylori induced gastric carcinoma
-
批准号:6522943
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2001
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
GENE EXPRESSION IN IMMORTAL HUMAN CELLS
-
批准号:2895135
-
项目类别:
-
资助金额:$8.91万
-
财政年份:1995
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
GENE EXPRESSION IN IMMORTAL HUMAN CELLS
-
批准号:2106476
-
项目类别:
-
资助金额:$8.37万
-
财政年份:1995
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
GENE EXPRESSION IN IMMORTAL HUMAN CELLS
-
批准号:2443087
-
项目类别:
-
资助金额:$8.91万
-
财政年份:1995
-
负责人:JEANMARIE HOUGHTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: